The Science

• DRAQ9™ is designed to allow live cell tracking or as a cell “painting” probe that is negative for the cell nucleus.It is optimally excited at 635 nm and detected in the far-red / NIR.

• DRAQ9™ is intended for fluorescence microscopy and high content imaging platforms.

Why DRAQ9™?

• DRAQ9™ labels membranous structures in the cell cytoplasm in live cells yet does not label the nucleus.
• DRAQ9™ is non-toxic and therefore allows the long-term tracking of cells.
• DRAQ9™ can also allow end-point labelling of cells for cell painting or mosaic analysis in phenotypic screening.
• DRAQ9™ can be combined with most visible-range chromophores including GFP and UV-excited probes including Hoechst
• DRAQ9™ can be combined with the nuclear-specific viability probe DRAQ7™ to allow monitoring of cell health while tracking cells.

Technical Information

• DRAQ9™ is a novel fluorescent dye that labels membranous structures in the cytoplasm.
• DRAQ9™ is LIVE cell permeant.It can be used on live or fixed cells.
• DRAQ9™ is non-toxic and can be used as a tracking dye for long-term, cell-based assays.
• DRAQ9™ can be used as a cell “paint” in high content phenotypic screening.
• DRAQ9™ does not crosslink with or esterify cytoplasmic proteins.
• DRAQ9™ does not label the cell nucleus.
• Products are shipped at ambient temperature, but on receipt packs should be stored at -20°C. DRAQ9™ can be repeatedly unfrozen for use and re-frozen without deterioration.

You can find much more technical information in the folders below:-

BioStatus由Paul Smith，Stefan Ogrodzinski和Laurence Patterson 于2000年成立。

从那时起，该公司有机地成长，形成了一个小型的可持续发展企业，并重新投资于研发，从而创建了三个衍生出来的制药公司-OncoTherics，BioSuspensions和BioTherics。

BioStatus被公认为开发新型远红荧光DNA染料的先驱。客户反馈认为BioStatus品牌是优质产品的代名词，这些产品为研究和诊断增加了真正的价值。

该公司在细胞分析方面提供深入的支持和优质的服务，在市场上被视为利基市场。

2012年10月，英国皇家化学学会授予BioStatus著名的“ 2012年创新团队合作奖”。该奖项是对公司“在药物发现，临床诊断和生命科学领域对新型荧光分子探针和细胞检测技术的全球开发和影响”的认可。